Recombinant Human Erythropoietin Treatment in Obstetric Anemia Patients / 中华围产医学杂志
Chinese Journal of Perinatal Medicine
; (12)2000.
Article
en Zh
| WPRIM
| ID: wpr-517214
Biblioteca responsable:
WPRO
ABSTRACT
Objective To investigate the efficacy of recombinant human erythropoietin(rHuEPO) in treating the anemia in obstrics. Methods 40 antepartum anemia patients and 36 postpartum anemia patients were treated with rHuEPO 8000IU intravenously. Another 40 antepartum and 36 postpartum anemia patients were selected as control. Oral supplementation of iron and folic acid were used both in study and control group. Results The hemoglobin level was increased significantly in the study group than control group both in the prenatal and postpartum anemia patients. ( P0.05 )。 Conclusion rHuEPO therapy for obstetric anemia is effective and safe.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Perinatal Medicine
Año:
2000
Tipo del documento:
Article